Mechanism & translational research
Discuss experimental models, target biology, and methods for evaluating a degradation strategy.
Different expertise.
A shared scientific question.
We welcome nonconfidential conversations with scientific collaborators, pharmaceutical companies, and investors interested in the company’s oncology research direction.
Bring complementary
perspectives to the work.
Possible discussion areas reflect prospective collaboration interests. They are not announcements of existing agreements or services available for purchase.
Drug-development expertise
Explore whether complementary capabilities in pharmacology, toxicology, formulation, or development planning could fit a defined project.
Potential licensing & alliances
Discuss program diligence and possible licensing or development structures, subject to confirmed rights and separate written agreements.
First, establish the fit.
A useful first exchange can begin with your organization, relevant expertise, area of interest, and a brief nonconfidential overview.
- 01
Share a short introduction
Describe the scientific or strategic question and the capabilities you would bring.
- 02
Agree on the discussion scope
Determine whether the topic fits and what information could be shared next.
- 03
Define any next steps in writing
Confidentiality, data access, rights, responsibilities, and economics require appropriate agreements.
SCIENTIFIC & STRATEGIC PARTNERSHIPSMove the science
Connect with Dvant Move the science
forward. Together.
Start a nonconfidential conversation with Dvant Pharma.